Beneficial Effect of Supplemental Lipoic Acid on Diabetes‐Induced Pregnancy Loss in the Mouse
- 28 November 2006
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1084 (1) , 118-131
Abstract
Abstract: Uncontrolled diabetes mellitus (DM) is an etiological factor for recurrent pregnancy loss, fetal growth disorders, and major congenital malformations in the offspring. Antioxidant therapy has been advocated to overcome the oxidant–antioxidant disequilibrium inherent in diabetes. The objective of this article was to evaluate the beneficial effects of α‐lipoic acid (LA) on fetal outcome in a mouse model of streptozotocin (STZ)‐induced DM. Timed pregnant mice were made diabetic by intraperitoneal (IP) injection of a single dose of STZ (200 mg/kg) on gestation day (GD) 2. Diabetic animals were supplemented daily with an IP injection of 15 mg/kg of LA starting on GD 4 and continued through GD 12. Fetuses were examined on GD 18 for malformations and growth restriction. Some diabetic mice injected with Evans blue were examined on GD 3.5 and GD 6.5 to evaluate frequency of implantations. STZ‐treated mice had all cardinal signs of DM. LA treatment did not normalize blood glucose levels of DM mice. Rates of pregnancy in saline control, DM, and DM + LA groups were 90%, 28%, and 64%, respectively, indicating that LA promotes pregnancy in DM animals. However, postimplantation resorption showed a threefold increase in the DM + LA group. Rates of intrauterine growth restriction and major congenital malformations were also augmented thus indicating that the interaction between DM and LA has deleterious effects on postimplantation embryos.Keywords
This publication has 40 references indexed in Scilit:
- Fetal Macrosomia – A Continuing Obstetric ChallengeNeonatology, 2006
- Molecular evaluation of foetuses with holoprosencephaly shows high incidence of microdeletions in the HPE genesHuman Genetics, 2005
- Are isolated facial cleft lip and palate associated with increased perinatal mortality? A cohort study from the West Midlands Region, 1995–1997The Journal of Maternal-Fetal & Neonatal Medicine, 2005
- Molecular screening ofSHH,ZIC2,SIX3, andTGIF genes in patients with features of holoprosencephaly spectrum: Mutation review and genotype-phenotype correlationsHuman Mutation, 2004
- For Debate: Fetal and early postnatal growth restriction lead to diabetes, the metabolic syndrome and renal failure*Diabetologia, 2003
- Epidemiology of holoprosencephaly and phenotypic characteristics of affected children: New York state, 1984–1989American Journal of Medical Genetics, 1997
- Histopathological Changes of the Placenta in Diabetes Induced by Maternal Administration of Streptozotocin during Pregnancy in the RatCongenital Anomalies, 1988
- Congenital malformations and intrauterine growth retardation in streptozotocin induced diabetes during gestation in the ratReproductive Toxicology, 1987
- Diabetic MacrosomiaObstetrics & Gynecology, 1986
- A critical comparison of the freehand razor‐blade dissection method according to Wilson with an in situ sectioning method for rat fetusesTeratogenesis, Carcinogenesis, and Mutagenesis, 1985